Increase (Decrease) in Operating Lease, Right-of-Use Asset

No definition available.

Name:	bhvn_IncreaseDecreaseInOperatingLeaseRightOfUseAsset
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Increase (Decrease) In Rent Expense

+ References

No definition available.

+ Details

Name:	bhvn_IncreaseDecreaseInRentExpense
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the amount of milestone payment to be paid by the company upon the achievement of specified commercial milestones and annual royalty payments based on net sales of products from patents.

+ References

No definition available.

+ Details

Name:	bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedCommercialMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Milestone Payment To Be Paid By Company Upon Specified Development Milestone Achievement

+ References

No definition available.

+ Details

Name:	bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedDevelopmentMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the amount of milestone payment to be paid by the company upon the achievement of specified regulatory milestones and annual royalty payments based on net sales of products from patents.

+ References

No definition available.

+ Details

Name:	bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedRegulatoryMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Operating Lease, Non-Cash Gain (Loss)

+ References

No definition available.

+ Details

Name:	bhvn_OperatingLeaseNonCashGainLoss
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Operating Lease, Reduction in Square Footage Area of Space Leased

+ References

No definition available.

+ Details

Name:	bhvn_OperatingLeaseReductionInSquareFootageAreaOfSpaceLeased
Namespace Prefix:	bhvn_
Data Type:	dtr-types:areaItemType
Balance Type:	na
Period Type:	instant

- Definition

Rent Expense, Annual Increase, Percentage

+ References

No definition available.

+ Details

Name:	bhvn_RentExpenseAnnualIncreasePercentage
Namespace Prefix:	bhvn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483049/450-30-50-1

+ Details

Name:	us-gaap_GainContingencyUnrecordedAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of increase (decrease) in obligation for operating lease.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (g)(1)
-SubTopic 20
-Topic 842
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478964/842-20-50-4

+ Details

Name:	us-gaap_IncreaseDecreaseInOperatingLeaseLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The minimum amount the entity agreed to spend under the long-term purchase commitment.

+ References

No definition available.

+ Details

Name:	us-gaap_LongTermPurchaseCommitmentAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of operating lease expense. Excludes sublease income.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 842
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479041/842-20-45-4

+ Details

Name:	us-gaap_OperatingLeaseExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 985
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481283/985-20-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-18

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482916/730-10-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 912
-SubTopic 730
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479532/912-730-25-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	srt_LitigationCaseAxis=bhvn_TradeSecretLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=bhvn_YaleUniversityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LeaseContractualTermAxis=bhvn_CambridgeLeaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=bhvn_ModaPharmaceuticalsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=bhvn_ModaAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Details)	1 Months Ended	3 Months Ended			9 Months Ended
Commitments and Contingencies (Details)	Apr. 30, 2026 USD ($) ft²	Sep. 30, 2026 USD ($)	Jun. 30, 2026 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2026 USD ($)	Sep. 30, 2025 USD ($)	Jul. 24, 2026 USD ($)
Other Commitments [Line Items]
Operating lease, non-cash gain (loss)	$ 155,000
Development milestone payment to be paid		$ 139,313,000			$ 139,313,000
Milestone payment to be paid upon regulatory achievement		711,600,000			711,600,000
Commercial milestone payment to be paid		3,187,488,000			3,187,488,000
Research and development		101,850,000		$ 141,169,000	306,491,000	$ 513,120,000
Trade Secret Litigation
Other Commitments [Line Items]
Awarded combined damages							$ 1,000,000
Trade Secret Litigation \| Yale University
Other Commitments [Line Items]
Awarded combined damages							$ 4,000,000
Cambridge Lease
Other Commitments [Line Items]
Reduction in area leased (in sq ft) \| ft²	2,858
Reduction in base rent	$ 400,000
Annual rent	$ 3,205,000
Annual rent, percent	3.00%
Decrease in operating lease right-of-use asset	$ 4,951,000
Decrease in operating lease liability	$ 5,106,000
Moda Pharmaceuticals LLC
Other Commitments [Line Items]
Research and development			$ 3,250,000
Moda Pharmaceuticals LLC \| Moda Agreement
Other Commitments [Line Items]
Development milestone payment to be paid		27,995,000			27,995,000
Milestone payment to be paid upon regulatory achievement		22,000,000			22,000,000
Commercial milestone payment to be paid		$ 104,612,000			104,612,000
Research and Development Arrangement
Other Commitments [Line Items]
Research commitments					$ 0